Grinspoon on Drugs
Dr. Peter GrinspoonDoctors. Drugs. Unfiltered opinions. The unvarnished truth. These are things that are rarely if ever, seen together. Here you can find an informed, objective alternative to the medical party line. Join me.
| Platform |  | Pricing | Freemium |
|---|---|---|---|
| Publishes | Weekly | Issues | 55 |
| Subscribers | Read | drpetergrinspoon.substack.com |
Curious about how many subscribers Grinspoon on Drugs has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Latest Issues
Recent posts by this newsletter. Browse the email archive.
Aversive Therapies for Addiction
Some addiction treatment is backed by science (e.g., medications for opioid use disorder such as methadone), some is backed by empathic, sensible behavioral policies (e.g., safe injection sites), much of it is based on well-intentioned vood...
Benzos! (Valium, Xanax, Klonopin, Ativan)
In the addiction clinic where I work, one would think most of our team discussions would center around fentanyl, which is killing almost one hundred thousand people a year, and which is most of what we treat. Our meetings are often hijacked...
Synthetic cannabinoids and cathinones
> Let’s Keep the Conversation Going
Grinspoon on Drugs – 2024 and beyond
Thanks to you my readers, 2024 has been an incredibly successful and meaningful year for my blog “Grinspoon on Drugs”. My writings are unique in that they are scientifically referenced, hand-written, and informed by my 25 years as a general...
Similar Newsletters
Other publications recommended by the authors of this newsletter.
Authors
The writers behind this newsletter.
Peter Grinspoon, M.D. is a primary care doctor at Massachusetts General Hospital, an Instructor in Medicine at Harvard Medical School, and has been a cannabis specialist for twenty-five years.
Frequently Asked Questions
How can I access the email archive for Grinspoon on Drugs?
You can find recent issues that have been published by Grinspoon on Drugs on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Grinspoon on Drugs have?
To see how many people subscribe to Grinspoon on Drugs, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Grinspoon on Drugs?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Grinspoon on Drugs as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Grinspoon on Drugs?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Grinspoon on Drugs using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to Grinspoon on Drugs?
Scroll up to where it says Similar Newsletters to see other publications like Grinspoon on Drugs. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Grinspoon on Drugs?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.